ASX:EMV EMVision Medical Devices (EMV) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free EMV Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume192,157 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get EMVision Medical Devices alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About EMVision Medical Devices Stock (ASX:EMV)EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… EMV Stock News HeadlinesApril 18, 2024 | msn.comThis EMS Device Tightens My Jawline in 10 MinutesApril 16, 2024 | msn.comJohnson & Johnson's bet on heart devices boosted sales — but it still missed analysts' expectationsApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 16, 2024 | appleinsider.comFuture Apple Vision Pro could help the user get life-saving medical adviceApril 5, 2024 | msn.comJohnson & Johnson to Buy Shockwave Medical for $13.1 Billion. It’s a Cardio Health Play.April 3, 2024 | ft.com‘Made in Australia’ drive aims to shift economy from ‘world’s quarry’ labelApril 1, 2024 | msn.comConcept Medical Receives US FDA IDE Approval For MagicTouch AVF To Improve Haemodialysis TreatmentMarch 26, 2024 | msn.comFDA May Ban Electroshock Devices Used on Some Psychiatric PatientsApril 23, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 20, 2024 | wsj.comEMvision Medical Devices Ltd.March 15, 2024 | finance.yahoo.comEMVision Medical Devices Ltd's (ASX:EMV) largest shareholders are retail investors with 54% ownership, insiders own 23%March 7, 2024 | msn.comMedical Guardian vs. Lively Medical Alert SystemsMarch 6, 2024 | msn.comBest Affordable Medical Alert SystemsMarch 4, 2024 | msn.comResearchers develop electron beam accelerator to sterilize medical equipmentMarch 4, 2024 | marketwatch.comHalma Buys Rovers Medical Devices for $92.1 MlnFebruary 28, 2024 | finance.yahoo.comEMVision Sets Sight on US With US$10M Keysight InvestmentFebruary 12, 2024 | news.yahoo.comNuvell Clinics has over 47 different medical lasers and devices to customize any facial procedureFebruary 8, 2024 | markets.businessinsider.comWest Coast Device Alliance Announces Formation at IME West 2024February 6, 2024 | sg.news.yahoo.comSpanx Appoints Caroline (Cricket) Whitton CEO and Jeanne Jackson Executive ChairFebruary 6, 2024 | ca.news.yahoo.comE-commerce startup ShipBob seeks to hire banks for 2024 IPO -sourcesFebruary 6, 2024 | bizjournals.comBoston Medical Devices NewsFebruary 5, 2024 | msn.comIs Apple's new Vision Pro a health care machine? Sharp Healthcare thinks soFebruary 5, 2024 | sg.news.yahoo.comExclusive-India anti-fraud agency probing Paytm and bank unit over forex violations - sourcesFebruary 5, 2024 | msn.comSnap is laying off 10 percent of its workforceFebruary 3, 2024 | finance.yahoo.comEMVision Medical Devices (ASX:EMV) shareholders have earned a 35% CAGR over the last five yearsJanuary 23, 2024 | msn.comA ‘massive chasm’ exists between patients and medtech companies: This startup has a solutionJanuary 22, 2024 | msn.comApple issues Vision Pro warning to users with certain medical conditions — Company warns several could be made worse by using headsetSee More Headlines Receive EMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMVision Medical Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/26/2019Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:EMV CUSIPN/A CIKN/A Webwww.emvision.com.au Phone61 2 8667 5337FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,220,000.00 Net Margins-37.17% Pretax MarginN/A Return on Equity-47.66% Return on Assets-16.10% Debt Debt-to-Equity Ratio52.07 Current Ratio1.91 Quick Ratio8.04 Sales & Book Value Annual Sales$8.68 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$0.07 per share Price / BookN/AMiscellaneous Outstanding Shares85,420,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.58 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Scott KirklandCEO, MD & Executive DirectorMs. Emma Waldon (Age 48)CFO & Company Secretary Ms. Forough KhandanChief Technology OfficerProf. Stuart Crozier B.E.M.Sc., Ph.D., Chairman of Clinical Advisory Board & Chief Scientific OfficerMr. Robert TillerHead of DesignDr. Konstanty BialkowskiHead of Tech DevelopmentDr. Christian WightHead of Regulatory AffairsMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersPhillip DuboisSold 500,000 sharesTotal: $850,000.00 ($1.70/share)Ronald (Ron) WeinbergerBought 223,602 shares on 5/5/2023Total: $1.25 M ($5.59/share) EMV Stock Analysis - Frequently Asked Questions How were EMVision Medical Devices' earnings last quarter? EMVision Medical Devices Ltd (ASX:EMV) issued its quarterly earnings results on Tuesday, February, 26th. The company reported ($4.47) earnings per share (EPS) for the quarter. EMVision Medical Devices had a negative net margin of 37.17% and a negative trailing twelve-month return on equity of 47.66%. This page (ASX:EMV) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressFed launches fourth dollar overhaulStansberry ResearchThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMVision Medical Devices Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
